ULORIC is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Aphena Pharma Solutions - Tennessee, Llc. The primary component is Febuxostat.
| Product ID | 43353-305_196bf4ca-b625-424a-8c4f-6be167d2bd2e | 
| NDC | 43353-305 | 
| Product Type | Human Prescription Drug | 
| Proprietary Name | ULORIC | 
| Generic Name | Febuxostat | 
| Dosage Form | Tablet | 
| Route of Administration | ORAL | 
| Marketing Start Date | 2009-02-13 | 
| Marketing Category | NDA / NDA | 
| Application Number | NDA021856 | 
| Labeler Name | Aphena Pharma Solutions - Tennessee, LLC | 
| Substance Name | FEBUXOSTAT | 
| Active Ingredient Strength | 40 mg/1 | 
| Pharm Classes | Xanthine Oxidase Inhibitor [EPC],Xanthine Oxidase Inhibitors [MoA] | 
| NDC Exclude Flag | N | 
| Listing Certified Through | 2020-12-31 | 
| Marketing Start Date | 2017-04-07 | 
| NDC Exclude Flag | N | 
| Sample Package? | N | 
| Marketing Category | NDA | 
| Application Number | NDA021856 | 
| Product Type | HUMAN PRESCRIPTION DRUG | 
| Billing Unit | EA | 
| Marketing Start Date | 2017-04-07 | 
| Ingredient | Strength | 
|---|---|
| FEBUXOSTAT | 40 mg/1 | 
| SPL SET ID: | 24ac0ee2-cd7b-4dda-a1bb-271e32331758 | 
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | 
| NDC | Brand Name | Generic Name | 
|---|---|---|
| 21695-516 | ULORIC | febuxostat | 
| 43353-305 | ULORIC | febuxostat | 
| 55154-5158 | ULORIC | febuxostat | 
| 55154-5159 | ULORIC | febuxostat | 
| 64764-677 | ULORIC | ULORIC | 
| 64764-918 | ULORIC | ULORIC | 
| 0054-0413 | Febuxostat | Febuxostat | 
| 0054-0414 | Febuxostat | Febuxostat | 
| 0378-3925 | Febuxostat | febuxostat | 
| 0378-3926 | Febuxostat | febuxostat | 
| 0527-2244 | FEBUXOSTAT | febuxostat | 
| 0527-2248 | FEBUXOSTAT | febuxostat | 
| 14445-156 | Febuxostat | Febuxostat | 
| 14445-157 | Febuxostat | Febuxostat | 
| 16714-059 | Febuxostat | Febuxostat | 
| 16714-060 | Febuxostat | Febuxostat | 
| 27808-206 | Febuxostat | febuxostat | 
| 27808-207 | Febuxostat | febuxostat | 
| 43547-295 | FEBUXOSTAT | febuxostat | 
| 43547-296 | FEBUXOSTAT | febuxostat | 
| 46708-190 | Febuxostat | febuxostat | 
| 46708-191 | Febuxostat | febuxostat | 
| 47335-721 | Febuxostat | Febuxostat | 
| 47335-722 | Febuxostat | Febuxostat | 
| 48792-7905 | FEBUXOSTAT | febuxostat | 
| 48792-7906 | FEBUXOSTAT | febuxostat | 
| 51407-293 | Febuxostat | Febuxostat | 
| 51407-294 | Febuxostat | Febuxostat | 
| 55111-796 | Febuxostat | Febuxostat | 
| 55111-797 | Febuxostat | Febuxostat | 
| 60687-538 | Febuxostat | Febuxostat | 
| 62332-190 | Febuxostat | febuxostat | 
| 62332-191 | Febuxostat | febuxostat | 
| 63304-864 | Febuxostat | Febuxostat | 
| Mark Image Registration | Serial | Company Trademark Application Date | 
|---|---|
|  ULORIC  85060525  3916684 Live/Registered | TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED) 2010-06-11 | 
|  ULORIC  78108573  2739132 Live/Registered | TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED) 2002-02-13 | 
|  ULORIC  77671366  not registered Dead/Abandoned | Takeda Pharmaceuticals North America, Inc. 2009-02-16 | 
|  ULORIC  77671352  3800552 Live/Registered | TEIJIN KABUSHIKI KAISHA (TEIJIN LIMITED) 2009-02-16 |